ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1474

Associations and Outcomes of Critical Peripheral Ischemia in Systemic Lupus Erythematosus (SLE): Data from Indian SLE Inception Cohort for Research (INSPIRE)

Vineeta Shobha1, Liza Rajasekhar2, Sandra Manuel3, Nayana V3, Ranjan Gupta4, Bidyut Das5, Parasar Ghosh6, Chengappa Kavadichanda7, Ashish J Mathew8, Manish Rathi9, Avinash Jain10, Sumithra Selvam3 and Amita Aggarwal11, 1St. John's National Academy of Health Science, Bangalore, India, 2Nizam's Institute of Medical Sciences, Madhapur, India, 3St. John's Research Institute, Bangalore, India, 4All India Institute of Medical Sciences, New Delhi, India, 5SCB medical college, Cuttack, India, 6Govt of West Bengal, Kolkata, India, 7Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India, 8Christian Medical College, Vellore, India, 9Postgraduate Institute of Medical education and Research, Chandigarh, India, 10SMS Medical College, Lucknow, India, 11Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India

Meeting: ACR Convergence 2023

Keywords: Outcome measures, Raynaud's phenomenon, Systemic lupus erythematosus (SLE), Ulcers, Vasculitis, Cutaneous

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1442–1487) SLE – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Among the cutaneous manifestations of SLE, critical peripheral ischemia (CPI) including digital infarcts and gangrene are considered rare, gangrene occurring only in about 0.2% as initial presentation and in 1.2% in the longest longitudinal cohort with a follow up of 44 years¹. Whether vasculitis or thrombosis or both contribute to these remains debated. We report the incidence, associations and outcome of digital infarcts and gangrene in the Indian Systemic Lupus Erythematosus(SLE) Cohort.

Methods: From the ongoing prospective INdian SLE inception cohort For Research (INSPIRE), baseline data on CPI was accessed with key terms: ‘Digital Infarct’ and ‘Digital gangrene’ in May 2023. Association with other clinical domains and autoantibodies including antiphospholipid antibodies were analysed between cases and controls (all others without digital infarcts or gangrene). Adjusted odds ratios were reported using multivariable logistic regression analysis to identify the factors associated with gangrene and or digital infarcts

Results: Of 2503 patients in the INSPIRE cohort, 79 (3.2%) patients had CPI at initial presentation. Their mean age was 28.7±9.5 years including 9 (11.3%) children and 76(96.2%) women. There were 92 events (gangrene 47, digital infarcts 45 and with both gangrene and infarcts in 13). The duration of CPI symptoms was 7.0 ±11.9 days. None of the CPI patients were smokers.

The presence of coexistent thrombosis AOR[10.2(3.91,24.5)](p< 0.001), Raynaud’s phenomenon AOR[6.41(1.83,17.4)] (p< 0.006) and longer disease duration prior to diagnosis AOR[1.01(1.00,1.02)] (p< 0.007) were significantly associated with the presence of CPI in SLE patients. The presence of anti Scl-70 antibody AOR[5.34(1.78,13) (p< 0.008) and the antiphospholipid antibodies including lupus anticoagulant {AOR for triple positivity [3.75(1.10,9.70)](p< 0.05)} were significantly associated with higher odds of CPI positivity.(Table 1) None of Scl-70 positive patients had features of scleroderma. The disease activity as measured by SLEDAI and the proportion of early mortality were similar in those with and without CPI.

Conclusion: Critical peripheral ischemia occurred in a higher proportion (3.2%) of SLE patients in the INSPIRE cohort as compared to earlier reports. Both prothrombotic state and vasculopathy contribute to its occurrence.

Supporting image 1

Abbreviations: ACL- Anticardiolipin Antibody , B2GP1- Beta 2 glycoprotein 1, SLEDAI- SLE disease activity index


Disclosures: V. Shobha: None; L. Rajasekhar: None; S. Manuel: None; N. V: None; R. Gupta: None; B. Das: None; P. Ghosh: None; C. Kavadichanda: None; A. Mathew: None; M. Rathi: None; A. Jain: None; S. Selvam: None; A. Aggarwal: None.

To cite this abstract in AMA style:

Shobha V, Rajasekhar L, Manuel S, V N, Gupta R, Das B, Ghosh P, Kavadichanda C, Mathew A, Rathi M, Jain A, Selvam S, Aggarwal A. Associations and Outcomes of Critical Peripheral Ischemia in Systemic Lupus Erythematosus (SLE): Data from Indian SLE Inception Cohort for Research (INSPIRE) [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/associations-and-outcomes-of-critical-peripheral-ischemia-in-systemic-lupus-erythematosus-sle-data-from-indian-sle-inception-cohort-for-research-inspire/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-and-outcomes-of-critical-peripheral-ischemia-in-systemic-lupus-erythematosus-sle-data-from-indian-sle-inception-cohort-for-research-inspire/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology